1. Home
  2. CHRS
  3. CHRS News

Latest Coherus BioSciences Inc. (CHRS) News on May 26, 2024

Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

3 days ago

Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Associated Press Finance

17 days ago

Coherus BioSciences: Q1 Earnings Snapshot

Thomson Reuters StreetEvents

2 months ago

Q4 2023 Coherus BioSciences Inc Earnings Call

Associated Press Finance

2 months ago

Coherus BioSciences: Q4 Earnings Snapshot

Remembering Charlie Munger

GuruFocus.com

6 months ago

Remembering Charlie Munger

Share on Social Networks: